Management of Patients

Download as pdf or txt
Download as pdf or txt
You are on page 1of 19

NEUROLOGY

Page Diagnosis: Cerebrovascular Accidents (CVA) – Ischemic


14 stroke
Investigations Plans
CT brain – urgent 1. Monitor vital signs
FBC 2. Keep nil by mouth
RP/LFT/Ca2+/Mg2+/PO4/C 3. Glasgow Coma Scale (GCS) charting
K 4. IV drip 3 pints NS/24 hours
PT/APTT/INR 5. RT insertion (if gag reflex absent)
RBS (reflo) stat 6. CBD insertion
FBS/FSL – within 24 H or 3 7. Ventilatory support
mo after stroke 8. Insulin therapy if reflo > 10 mmol/L
ECG 9. Target INR is 2.0 – 3.0 (except in prosthetic
CXR valve)
ECHO 1.6 – 2.5: elderly age >75
LP – if suspect SAH 2.5 – 3.5: bileaflet or tilting disc valve
Young patients: 3.0 – 4.0: caged ball or caged disc valves
- ANA 10. Medications:
- Anti- - T. Aspirin 75 mg OD (withhold if
cardiolipin hemorrhagic stroke)
- Lupus - T. Lovastatin 20 mg ON
anticoagul - T. Prochlorperazine (stemetil) 1.5 mg
ant TDS
- Lactate - T. Dabigatran (direct anti-thrombin
- Protein C inhibitor) 110 mg – 150 mg BD
- Protein S 11. Withhold anti hypertension
- 12. Refer to stroke team for rehabilitation (speech
Antithrom therapy, physiotherapy)
bin III 13. For family to buy DVT stockings
- Homocystein
level
- Activated
protein C
resistance
- Prothrombin
gene
mutation
- Factor V
Leiden

Diagnosis: Cerebrovascular Accidents (CVA) –


Hemorrhagic stroke (Subarachnoid Hemorrhage – SAH)
Investigations Plans
CT brain – urgent 1. Monitor vital signs
FBC 2. Keep nil by mouth
RP/LFT/Ca2+/Mg2+/PO4/C 3. Glasgow Coma Scale (GCS) charting
K 4. IV drip 3 pints NS/24 hours
PT/APTT/INR 5. RT insertion (if dizziness)
RBS (reflo) stat 6. CBD insertion
FBS/FSL – within 24 H or 3 7. Ventilatory support
mo after stroke 8. MAP should be kept around 110 mmHg
ECG Target BP: 160/90 mmHg
CXR Cerebral Perfusion Pressure (CPP): 60 – 80 mmHg
ECHO 9. Insulin therapy if reflo > 10 mmol/L
LP – if suspect SAH 10. Target INR is 2.0 – 3.0 (except in prosthetic
MRI valve)
Angiography 1.6 – 2.5: elderly age >75
Young patients: 2.5 – 3.5: bileaflet or tilting disc valve
- ANA 3.0 – 4.0: caged ball or caged disc valves
- Anti- 11. Medications:
cardiolipin - T. Omeprazole 20 mg ON
- Lupus - IV Mannitol
anticoagul 12. Refer to neurosurgeon (HKL)
ant 13. For family to buy DVT stockings
- Lactate
- Protein C
- Protein S
-
Antithrom
bin III
- Homocystein
level
- Activated
protein C
resistance
- Prothrombin
gene
mutation
- Factor V
Leiden

Diagnosis: Epilepsy/Seizure
Investigations Plans
FBC 1. Prop up patient
RP/LFT/Ca2+/Mg2+/PO4/C 2. Monitor vital signs
K 3. Keep nil by mouth
RBS (reflo) stat 4. For oxygen therapy
ECG 5. Fit and GCS charting
CXR 6. For CBD and RT insertion
7. Medications:
- IV Diltiazem 5 mg PRN
- T. Epilim 300 mg BD


Shakir Ariff Bin Zulkifli | Management of Patients

PULMONOLOGY
Diagnosis: Acute Pulmonary Oedema (APO)
Investigations Plans
FBC 1. Prop up patient
RP/LFT/Ca2+/Mg2+/PO4/C 2. Monitor vital signs
K 3. High flow mask (FM) O2 10 L/min
Page CKMB/Trop I (within 6 4. SpO2 monitoring 4 hourly
14 hours) 5. Medications:
PT/APTT/INR - IV Furosemide 60 – 80 mg stat & TDS
ABG - IV Morphine 2.5 – 5 mg stat
ECG - S/L GTN I/I PRN
CXR a. T. Digoxin 0.125 (if atria l fibrillation
ECHO (AF))
URINE FEME 6. Fluid restriction to 500 – 800 ml/day
7. Strict I/O charting
8. Withhold beta-blocker in acute episode
9. May need IV Aminophylline 250 – 500 mg stat
10. For ECHO later
11. To inform if SOB/chest pain

Diagnosis: Pleural Effusion


Investigations Plans
FBC 2. Prop up patient
RP/LFT/Ca2+/Mg2+/PO4/C 3. Monitor vital signs
K 4. SpO2 monitoring 4 hourly (Keep SpO2 > 98%)
CKMB/Trop I (within 6 5. For therapeutic and diagnostic pleural tapping
hours) 6. KIV to start anti-TB if (+) TB
PT/APTT/INR 7. KIV refer respi team
ESR Light’s Criteria
CRP TRANSUDATE EXUDATE
ABG Se. protein < 0.5 > 0.5
Sputum AFB x 3 Se. LDH < 0.6 < 0.6
Sputum C+S
Comments Uncomplicated
CXR
Complicated:
Peritoneal tapping:
• pH < 7.2
- Tissue à
• Glucose
cytology
- Biochemical: < 3.3
- Protein mmol/L
- Glucose • LDH
- pH high
- LDH Causes Increased venous Increased leakiness of
- Amylase pressure/ pleural capillaries
- C+S hypoalbuminaemia/ secondary to infection/
- AFB hypothyroidism and inflammation/
Meig’s syndrome malignancy

Diagnosis: Acute Exacerbation of Bronchial Asthma


(AEBA) secondary to chest infection
Investigations Plans
FBC 1. Prop up patient
RP/LFT/Ca2+/Mg2+/PO4/C 2. Monitor vital signs
K 3. High flow mask O2 5 L/min PRN
ABG pre and 1H post oxygen 4. SpO2 monitoring 4 hourly
PEFR pre and post nebulizer 5. Maintain Sp)2 > 88 – 90%
Blood C+S 6. To repeat ABG an hour after administration of
Sputum C+S oxygen
Sputum FEME 7. Neb Ipratropium bromide (Atroven)/ Salbutamol
CXR – Albuterol sulphate (Ventolin)/ Normal saline
(AVN) 1:2:1 or combivent 2/4/6 hourly
8. Medications:
- IV aminophylline 250 mcg over 20
min (do not give bolus to patient’s
taking oral) – severe/life-threatening
- IV Hydrocortisone 100 mg TDS (or T.
Predsinolone 30 mg – 60 mg OD for
5 – 10 days)
- IV MgSO4 2g (4ml) given over 20 min
– severe/life-threatening
- MDI Budesonide 400 mcg BD
- MDI Salbutamol 2 puffs PRN
- Syr. Benadryl 15 ml TDS
(asthma/COPD pt)
- T. Bisolvon 8 mg I/I TDS
Mild CAP (1 week)
- T. Augmentin 1.2g stat & TDS (or T.
Augmentin 625 mg BD) OR
- T. EES 800 mg BD (or T.
Azithromycin 500 mg OD)
- Recent antibiotics: both
Moderate and Severe CAP (1 week)
- IV Azithromycin 500 mg OD PLUS
- T. Augmentin 625 mg BD
Lung Abscess/Empyema (4 – 6 weeks)
- IV Ceftriaxone 2g OD PLUS
- IV Metronidazole 500 mg TDS & T.
Metronidazole 400 mg TDS
Acute Exacerbation of Chronic Bronchitis
- T. Azithromycin 500 mg OD
- Pseudomonas aeruginosa:
T. Ciprofloxacin 500 mg BD
9. To assess and teach MDI technique by
pharmacist
10. For chest physiotherapy
11. To inform if SOB worsening/chest tightening

Diagnosis: Pneumonia
Investigations Plans
FBC 1. Prop up patient
RP/LFT/Ca2+/Mg2+/PO4/C 2. Monitor vital signs
K 3. O2 PRN
ESR/CRP 4. SpO2 monitoring 4 hourly
Cold agglutinin (if suspect 5. IV drip 2 – 3 pints/24 hours
mycoplasma) 6. Tepid sponging (if fever)
Page Blood C+S 7. Neb AVN 1:2:1 stat & 6 hourly
Sputum C+S 8. Medications:
14 Sputum FEME - IV Augmentin 1.2 g stat & TDS (or T.
Sputum AFB x 3 Augmentin 625mg BD)
ABG - Syr. Benadryl 15ml TDS
CXR - IV Rocephin (if partially
Pleural aspiration (if effusion treated/HAP/aspiration)
(+)) - T. Bisolvan 8mg I/I TDS (if (+)
Bronchoscopy (lung abscess) sputum but can’t cough)
ECHO - T. EES 400 mg BD (or T.
URINE FEME Azithromycin 500 mg OD)
Atypical Pneumonia: Mild CAP (1 week)
- Serology for - T. Augmentin 1.2g stat & TDS (or T.
mycoplas Augmentin 625 mg BD) OR
ma, - T. EES 800 mg BD (or T.
Chlamydia Azithromycin 500 mg OD)
, legionella - Recent antibiotics: both
- PCR Moderate and Severe CAP – not requiring
- mechanical ventilation (1 week)
Immunoflo - IV Azithromycin 500 mg OD PLUS
rescence/ - T. Augmentin 625 mg BD
Giemsa - Pseudomonas infection:
staining IV Piperacillin/Tazobactam 4.5 g IV TDS PLUS
for IV Gentamicin 5 mg/kg OD PLUS
Pneumocy IV Azithromycin 500 mg OD
stis carinii Moderate and Severe CAP – requiring mechanical
ventilation (1 week)
- IV Ceftriaxone 2g OD PLUS
- IV Azithromycin 500 mg OD
- Klebsiella pneumonia (ESBL)
IV Imipenem 500 mg QID
- MRSA
IV Vancomycin 1g BD
Lung Abscess/Empyema (4 – 6 weeks)
- IV Ceftriaxone 2g OD PLUS
- IV Metronidazole 500 mg TDS & T.
Metronidazole 400 mg TDS
9. For chest physiotherapy
10. Ill patients not responding to conventional
treatment:
- Bronchoalveolar lavage
- Percutaneous lung aspiration
- Lung biopsy (transbronchial/open lung
biopsy)

Diagnosis: Tuberculosis (TB)


Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/Ca2+/Mg2+/PO4/C 2. Face mask 5L O2/min
K 3. KIV to start anti-TB
ESR/CRP 4. O2 therapy if needed
Sputum Acid Fast Bacilli
(AFB) x3
Sputum FEME
Sputum C+S
Mantoux test
CXR

Shakir Ariff Bin Zulkifli | Management of Patients

CARDIOLOGY
Diagnosis: Acute Coronary Syndrome (ACS)
Page Investigations Plans
14 FBC
RP/LFT/AST/Ca2+/Mg2+/PO4/
1. Prop up patient and rest in bed
2. Monitor vital signs
CK 3. BP every 15 – 30 minutes then 1 – 2 hourly
LDH 4. O2 PRN
FBS/FSL 5. SpO2 monitoring 4 hourly
CK/CKMB/Trop I 6. ECG daily & on chest pain
PT/APTT/INR 7. Maintain INR: 1.5 – 2.5
ABG 8. Medications:
ECG – stat & post streptokinase - IV Morphine 2.5 mg – 5 mg PRN
FSL CM - IV Maxolon 10 mg PRN (and on
RBS (reflo) stat morphine)
- S/C Clexane 60 mg stat and BD x
3/7
- S/C Fundaparinox (factor Xa
inhibitor) 2.5 mg OD (not for
renal impairment pt)
- S/L Glycerin Trinitrate (GTN) I/I
PRN
- T. Aspirin 300 mg stat & 75 mg OD
(not for ICB pt)
- T. Isordil 10 mg BD/TDS
- T. Lovastatin 20 mg ON
- T. Vasteral (anti-ischemic) 20 mg
TDS
9. To inform if SOB/chest pain

Diagnosis: Acute Coronary Syndrome (ACS) - STEMI


Investigations Plans
FBC 1. Prop up patient and complete rest in bed
RP/LFT/Ca2+/Mg2+/PO4/C 2. Monitor vital signs
K 3. O2 PRN
LDH 4. SpO2 monitoring 4 hourly
CK/CKMB/Trop I 5. ECG monitoring for 48 hours and if chest pain
PT/APTT/INR 6. To inform if SOB/chest pain
FBS/FSL CM 7. Medications:
RBS (reflo) stat - IV Furosemide (Lasix) 40 mg OD/BD
ABG - IV Maxolon 10 mg PRN (and on
ECG Morphine)
- stat - IV Morphine 2.5 mg – 5 mg PRN (if
- post improve after S/L GTN)
streptoki - IV Streptokinase 1.5 million units in
nase 100 ml saline over 60 min
CONTRAINDICATION: recent surgery, bleeding
tendency, recent MI, recent streptokinase, on anti-
coagulant
- S/C Fundaparinox 2.5 mg OD x 5/7
(not for renal impairment pt)
- S/L Glycerin Trinitrate (GTN) I/I PRN
- Syr. Lactulose 15ml TDS
- T. Alprazolam (Xanax) 0.5 mg ON
- T. Aspirin 300 mg stat & 75 mg OD
(not for ICB pt)
- T. Clopidogrel (Plavix) 75 mg OD x
1/12
- T. Lovastatin 20 mg ON
- T. Metoprolol 25 – 50 mg BD
- T. Perindopril 2 – 4 mg OD (target: 8
mg OD)

Diagnosis: Fast Atrial Fibrillation (AF)


Investigations Plans
FBC 1. Rest in bed
RP/LFT/Ca2+/Mg2+/PO4/C 2. Monitor vital signs
K 3. ECG chest pain
PT/APTT/INR 4. To inform if SOB/chest pain
TFT 5. Cardiac monitoring
FBS/FSL ​ 6. Medications:
RBS (reflo) stat - IV Amiodarone 300 mg in 100 ml
ECG 0.5% over 1 hour & 400 – 800 mg
CXR for next 23 hours
ECHO - S/C Clexane 60 mg stat & BD
If fast AF due to ACS,
- T. Aspirin 300 mg stat & 75 mg OD
(not for ICB pt)
- T. Amiodarone 200 mg TDS 1/52 à
200 mg BD 1/52 à 200 mg OD 1/52
- T. Lovastatin 20 mg ON
- T. Perindopril 2 – 4 mg OD
7. Counsel for warfarin
8. Aim:
Rate control: T. Propranolol 20 – 80 mg TDS OR T.
Metoprolol 50 mg TDS
Rhythm control: T. Digoxin 0.125 mg OD
Anti-thrombotic: clexane

Diagnosis: Congestive Cardiac Failure (CCF)


Investigations Plans
FBC 1. Prop up patient
RP/LFT/Ca2+/Mg2+/PO4/C 2. Monitor vital signs
K 3. High flow mask (FM) O2 10 L/min & PRN
Trop I 4. SpO2 monitoring 4 hourly (maintain SaO2:
ECG >90%)
CXR 5. Neb AVN 1:2:1 stat & 6 hourly
RBS (reflo) 6. Fluid restriction to 1000 ml/day
Urine FEME 7. Strict I/O charting
ECHO 8. ECG on chest pain
9. Medications: (to continue old meds)
- IV Furosemide 40 – 80 mg TDS
- S/L GTN I/I if systolic BP > 100
mmHg
- T. Aspirin 74 mg OD
- T. Digoxin 0.125 mg OD
- T. Lovastatin 20 mg ON
- T. Metoprolol 50 mg OD
- T. Omeprazole 20 mg OD
- T. Slow K+ 1.2 g BD
Page 10. To inform if SOB/chest pain

14
Diagnosis: Hypertensive Crisis (Emergency/Urgency)
Investigations Plans
FBC 1. Prop up patient
RP/LFT/Ca2+/Mg2+/PO4/C 2. Monitor vital signs
K 3. To keep BP at 160/90 mmHg (diastolic BP: 100-
PT/APTT/INR 110 mmHg)
FSL Emergency: within a few hours – to prevent organ
ABG damage
Blood C+S Urgency: slowly
ECG stat 4. BP hourly till stable (BP control within 4 hours)
Funduscopy 5. CBD insertion
UFEME 6. Medications:
CXR CAD and Heart Failure
- IV GTN 50 mg in 250 ml NS or D5%
= 200mcd/ml; 10 mcg/min :
3ml/hour
* Start at 5 – 10 mcg/min and titrate until desired
BP is achieved (max: 200 mcg/min)
Pheochromocytoma
- T. Prazosin (thiazide) 0.5 mg stat and 1
mg TDS (if no hypokalemia)
Aortic Dissection
- IV Esmolol 2.5 g in 250 ml NS or
D5% to a concentration of 10 mg/ml
Loading dose: 500 mcg/kg/min for 1 min;
Maintenance dose: 50 mcg/kg/min and titrate (not
more than every 4 min within a range of 50 – 200
mcg/kg/min)
Pulmonary Oedema
- IV Furosemide / IV GTN
Hypertension in pregnancy
- IV Hydralazine 50 mg in 500 ml NS =
100 mcg/ml; 50 mcg/min = 30
ml/hour
5 – 20 mg, repeated if necessary at about 15 – 30
min interval
IVI Hydralazine 50 – 150 mcg/min
- IV Labetolol 25 – 50 mg over 1 – 5
min repeated every 5 – 10 min until
max dose of 200 – 300 mg or until
desired BP achieved (T. Labetolol
200 mg BD)
IVI Labetolol 200 mg in 200 ml D5% running at 1
– 2 mg/min (1 – 2 ml/min)
*Excessive bradycardia: IV Atropine 0.5 – 2 mg in
divided doses of 0.5 mg
- IV MgSO4
Stroke
- IV Esmolol/T. Amlodipine 10 mg BD
7. To refer ENT if BP still high

Shakir Ariff Bin Zulkifli | Management of Patients

GASTROENTEROLOGY & HEPATOLOGY


Diagnosis: Acute Gastroenteritis (AGE)
Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/Ca2+/Mg2+/PO4/C 2. IV drip 3 – 5 pints NS/24 hours (see hydration
K status)
Blood C+S (if fever) 3. Correct electrolytes accordingly
Stool FEME 4. Encourage oral intake
Stool C+S 5. Strict I/O charting
Stool ova + cyst 6. Medications:
Stool occult blood HEALTHY: 5 days
Urine FEME IMMUNOCOMPROMISED: longer
Urine C+S - Infection:
Empirical
IV Ciprofloxacin 500 mg BD or T. Ciprofloxacin
400 mg BD for 3 – 5/7
Specific
Salmonella septicaemia: IV Ciprofloxacin 400 mg
BD
Severe shigellosis: T. Ciprofloxacin 500 mg BD
Severe campylobacter: T. EES 250 mg TDS/ T.
Ciprofloxacin 500 mg BD
Giardiasis: T. Metronidazole 400 mg TDS
Amoebic dysentery: T. Metronidazole 800 mg
TDS
Traveller’s diarrhea: T. Ciprofloxacin 500 mg BD
- IV Metoclopramide (Maxolon) 10 mg
stat & TDS
- IV Ranitidine 50 mg TDS
- ORS per purge
- Anti diarrhea (not for dysentery)
- T. Diphenoxylate 5 mg à 1 tab each loose
stool
- T. Loperamide 4 mg à 1 tab each loose
stool
- T. Lomotil I/I stat & TDS

Diagnosis: Gastro-esophageal Reflux Disease (GERD)


Investigations Plans
RP ​ 1. Monitor vital signs
2. Correct all electrolytes accordingly
3. Medications:
- IV or C. Omeprazole 20 mg / 40 mg OD
- Syr. MMT 15 ml TDS
- T. Ranitidine 150 mg BD

Page
14

Diagnosis: Upper Gastrointestinal Bleeding (UGIB)


Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/Ca/Mg/PO4 2. Secure airway (intubate if necessary)
PT/APTT/INR 3. RT insertion – free flow
GXM 4. Strict I/O chart
RBS (reflo) 5. Correct all electrolytes accordingly
ECG ​ 6. KIV central line for CVP
7. KIV FFP if INR > 1.5
8. Medications:
- IV or C. Omeprazole 20 mg / 40 mg OD
- Syr. MMT 15 ml TDS
- T. Ranitidine 150 mg BD

Diagnosis: Alcoholic Liver Disease (ALD)


Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/Ca2+/Mg2+/PO4 2. Watch out for uremic symptoms
RBS/FSL 3. Daily weight measurement
PT/APTT/INR 4. Diet: low salt/protein and high calorie diet
Alpha-fetoprotein (FTP) 5. Restrict fluid
Hep B/Hep C 6. Strict I/O charting
USG Hepato-biliary system 7. Medications:
(HBS) - T. Spironolactone 100 mg BD
- T. Furosemide 40 mg BD
- T. Thiamine 100 mg BD
8. KIV stab peritoneal tapping if symptomatic


Shakir Ariff Bin Zulkifli | Management of Patients

POISONING & DRUG OVERDOSE


Diagnosis: Paracetamol Poisoning (>150 mg/kg in children
or 20 tablets in adults)
Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/AST- daily 2. Suicidal precaution
Bilirubin - daily 3. Keep nil by mouth
PT/APTT/INR daily 4. IV drip 4 – 5 pints NS/24 hours
Se. acetaminophen (4H, 8 - 5. Correct electrolytes accordingly
24H) 6. Ryles tube (RT) insertion – free flow
Se. cholinesterase (4H, 8H) 7. Gastric lavage if present within an hour
Se. salicylate (4H, 8H) 8. Activated charcoal stat 1g/kg if present within 4
Urine paraquat hours (10 tabs TDS)
VBG 9. IV Vitamin K (correct hypoprothrombonaemia)
Suspected fulminant liver 10. Medications:
failure: - IVI N-acetyl-cystein continuous in D5%
- Serum - 150 mg/kg in 200 ml over 15 min
glucose - 50 mg/kg in 500 ml over 4 hours
- ABG - 100 mg/kg in 1000 ml over 16 hours
- IV Ranitidine 50 mg TDS (if allergic to
acetylcystein)
- T. Acetylcysteine 140 mg/kg stat & 70
mg/kg every 4 hours for 17 additional
doses
- T. Ranitidine 150 mg BD
*Hepatic failure need longer duration of >72 hours until
clinical improvement seen or INR <2.0
11. Refer psychiatry

Diagnosis: Organophosphate Poisoning


Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/Ca2+/Mg2+/PO4 2. Keep nil by mouth
PT/APTT/INR 3. Ryles tube (RT)insertion with 4 hourly
ABG aspiration/free flow
Se. acetaminophen (4H, 8 - 4. Cardiac monitoring
24H) 5. Gastric lavage if possible
Se. cholinesterase (4H, 8H) 6. IV fluids 3 pints NS
Se. salicylate (4H, 8H) 7. Medications:
Urine paraquat - IV Pralidoxine 1 g TDS x 1/7
Urinary sodium - IVI Atropin 5 mg/hour
diphosphate - Maintain pupils dilatation
Urine FEME - PR > 120
ECG - T. Charcoal 50 g stat and 25 g 4 hourly
RBS (reflo) 8. Allow liquid diet when patient is able to tolerate
CXR – every 3 days orally

Diagnosis: Paraquat Poisoning


Investigations Plans
FBC – every 3 days 1. Monitor vital signs
RP/LFT/Ca2+/Mg2+/PO4 2. Avoid oxygen unless PaO2 falls <60 mmHg or
– every 3 days patient is severely dyspnoea
RP daily 3. Ryles tube (RT)
ABG 4. Gastric lavage if possible
Gastric lavage/aspirate, 5. IV fluids 4 – 5 L/day (NS and D5%) for first
urine and blood for 24hours then 3L/day orally or IV for several days
toxicology screening 6. Strict I/O charting
Lavage for paraquat 7. Watch out for SSx of fluid overload
Urine for paraquat 8. To correct electrolytes accordingly
Urinary sodium 9. Medications:
Page diphosphate - 300 ml Fuller’s earth (15% suspension)
14 CXR – every 3 days via nasogastric tube (NGT) ASAP then
20 ml Fullers’s earth hourly, till
diarrhea complete PR passage of
Fuller’s earth OR
- Activated charcoal 50 g stat and 25 g 4
hourly for several days OR
- MgSO4 30 ml 4 hourly till diarrhea and
passage of Fuller’s earth OR
- Mannitol 20% 200 – 250 ml stat
- IV Furosemide 40 mg BD or T.
Furosemide 40 mg BD
- IV Methylprednisolone 15 mg/kg +/- IV
Cyclophophamide 15 mg/kd followed
by IV Dexamethasone at high doses
10. Allow liquid diet when patient is able to tolerate
orally


Shakir Ariff Bin Zulkifli | Management of Patients

ENDOCRINOLOGY
Diagnosis: Uncontrolled Diabetes Mellitus (DM)
Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/Ca2+/Mg2+/PO4 2. Withhold OHA
FBS/FSL 3. Continue other medications
RBS (reflo) stat and hourly 4. For diabetic diet and counseling
VBG 5. Medications:
ABG Reflo 15 – 20 mmol/L
Urine ketone stat and - S/C Actrapid 6 – 8 units stat then TDS
hourly - Omit if < 6 mmol/L
Urine FEME - Reflo an hour later
- Withhold OHA
- Continue other medications
Reflo > 20 mmol/L
- S/C Actrapid 10 – 12 units stat
- Reflo an hour later
- Inform MO
- KIV Insulin sliding scale

Diagnosis: Diabetic Ketoacidosis (DKA)


Investigations Plans
FBC 1. Monitor vital signs and reflo hourly
RP/LFT/Ca2+/Mg2+/PO4 2. IV drip 4 – 5 L/day with NS
RBS (reflo) stat and - 1 L over 1 H
hourly - 1 L over 2 H
VBG - 1 L over 4 H
ABG - 1 L over 6 H
Urine ketone stat - 1 L over 8 H
Urine FEME 3. If reflo <15 mmol/L, to over ride with IV DS
CXR 4. To correct any electrolyte imbalances
5. Medications:
- S/C Actrapid 6 units stat
- IV Insulin sliding scale
To start at 6 units/hour
To give stat IV actrapid if reflo HIGH
To reduce insulin to 3 units/hour if reflo <15 mmol/L
and change all IVD regime to DS

Diagnosis: Hyperglycemia (reflo: > 15 mmol/L)


Investigations Plans
Reflo stat 1. Monitor vital signs
VBG 2. Medications:
Urine ketone - S/C Actrapid stat

Diagnosis: Hypoglycemia
Investigations Plans
FBC 3. Monitor vital signs
RP/LFT/Ca2+/Mg2+/PO4 4. Watch out for SSx of hypoglycemia
RBS (reflo) stat 5. IV drip 1pint D10%/24 hours
FSL/FBS CM 6. Encourage oral intake
Urine FEME 7. Strict I/O charting
CXR 8. If insulin/OHA overdose:
- > 3 mmol/L: encourage orally
- < 2 mmol/L:
D50%/50 cc stat
IVD ½ pint D5/24 hours

Diagnosis: Nephrotic Syndrome (triad: proteinuria,


hypoalbuminaemia (alb: <25), oedema)
Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/AST/Ca2+/Mg2+/P 2. Monitor BP 2 hourly (Target BP: 125/75 mmHg)
O4 3. KIV to refer nephro
FSL 4. Nephrotic chart
PT/APTT/INR 5. Daily weight measurement
ESR 6. Diet: low salt and high protein diet
Blood C+S 7. Restrict fluid: 1L/day
HIV/Hep B/ Hep C 8. Strict I/O charting
C3, C4, ANA, dsDNA 9. Medications:
Urine FEME - T. Furosemide 40 mg BD
24 hour urine protein 10. For ACE Inhibitor later (T. Perindopril 2mg
CXR OD)


Page Shakir Ariff Bin Zulkifli | Management of Patients
14

NEPHROLOGY
Diagnosis: Acute Renal Failure (ARF)
Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/Ca2+/Mg2+/PO4/C 2. Watch out for SSx of uraemia
K 3. Fluid management:
ESR/CRP Hypotensive patients:
ANF/anti dsDNA - Fluid challenge with 250 ml NS over
Urine FEME 15 min
Urine C+S - If CVP does not increase by 2 cm, to
ECG repeat fluid challenge up to 500 –
CXR 1000 ml NS
AXR - Stop if CVP: 5 – 10 cmH2O
USG Kidney-Ureter-Bladder - Establish urine > 40 ml/hour
(KUB) - If not, give IV Furosemide 40 – 120
mg at 10 – 30 mg/hour
Euvolaemic patients:
- Start IV Furosemide as above
Fluid overload patients:
- Restrict fluid
- Start IV Furosemide as above
- Consider dialysis if not improved
4. Blood pressure
Hypotension
- Volume expansion, vasopressors
Hypertension
- BP should be controlled
5. Correct any electrolyte imbalances
Metabolic acidosis
0.5 x Body weight (kg) x Base deficit
Base deficit: 24 – Actual HCO3
1 ml of 8.4% NaHCO3 provides 1 mmol/L of NaHCO3
6. Nutrition:
Protein: 0.8 – 1.2 g/kg/day (higher protein intake if in
hypercatabolic state)
NaCl: 2 – 4 g/day
Caloric intake: 35 – 50 kcal/kg/day
Potassium: 40 mmol/day (if dialysed)

Diagnosis: Urinary Tract Infection (UTI)


Investigations Plans
FBC 1. Monitor vital signs
RP/LFT/Ca2+/Mg2+/PO4/C 2. Tepid sponging
K 3. Medications:
ESR/CRP Uncomplicated UTI
RBS - IV Cefuroxime 1.5 g stat & 750 mg
Urine FEME TDS or T. Cefuroxime 250 - 500 mg
Urine C+S BD for 3-7/7
AXR Complicated UTI
USG KUB - Same as above but 7-10/7 according to
C+S

Shakir Ariff Bin Zulkifli | Management of Patients

METABOLIC & ELECTROLYTES DISORDERS


Diagnosis: Hyperkalemia (K+ >5.5)
Investigations Plans
RP 1. Monitor vital signs
ECG stat 2. Check sample lysed/not
- Tall T 3. Stop all medications causing hyperkalemia
- Prolonged Diuretic/ACE-inhibitor/mist KCl/spironolactone
PR 4. Medications:
interval - Sodium polystyrene sulphonate
- Broad QRS (Resonium – K+ binder): 15 – 30
complex mg 3- 4 times daily OR
- Small P - Calcium polysterene sulphonate
wave (Kalamate): 5 – 10 mg TDS 3 – 4
- “sign wave” times daily
- As enemas:
Resonium: 30 g in 100 ml 3 – 4 times daily OR
Kalamate: 30 – 60 g in 200 ml 3 – 4 times daily
- Furosemide/Thiazide
5. KIV lytic cocktail/insulin chase:
- IV Ca gluconate 10% 10 ml within 2-5
minutes/10 minutes
- IV Actrapid 10 units in 50 ml 50%
dextrose (infused over 30 min) with
cardiac monitoring
- Continuous dextrose infusion D5%
- 50 ml of 8.4% NaHCO3 over 5
minutes or diluted with D5%
6. Alternatives:
- IV Sodium bicarbonate 100 – 200 ml
in 15 – 30 min
- IV Salbutamol 0.5 mg in 15 min or 10
mg (nebulizer)
7. For hemodialysis or peritoneal dialysis if above
fails

Diagnosis: Hypokalemia (K+ <3.5 )


Deficit:
(4.0 – K+) x 0.6 x body weight
13.4 (mmol/L)
Page Investigations Plans
14 RP/Ca2+/Mg2+ 1. Monitor vital signs
- Slow correct: repeat 2. Stop all medications causing hyperkalemia
CM or after 3/7 Diuretic/ACE-inhibitor/mist KCl
- Fast correct: repeat 3. Medications:
within an hour 2.5 – 3.4 mmol/L (slow correction)
stat - Mist KCl 15 ml TDS x 3/7
TFT - Slow K+ 1.2 g OD
ECG stat - Add 1g KCl in each pints of 4 pints NS
< 2.5 mmol/L (fast correction)
- 1 g KCl in 100 NS/1hour
< 2.0 mmol/L (fast correction)
- 2 g KCL in 200 NS/2 hours

Shakir Ariff Bin Zulkifli | Management of Patients

OTHERS
Diagnosis: Allergies
Investigations Plans
FBC 1. Monitor vital signs
2. Medications:
- IV or T. Piriton 10 mg TDS
- IV Ranitidine 50 mg TDS
- T. Hydrocortisone 100 mg TDS
- T. Prednisolone 30 mg OD

Diagnosis: Symptomatic Anaemia


Investigations Plans
FBC, reticulocyte count 1. Monitor vital signs
FBP 2. IV drip 5 pints NS/24 hours
GXM 2 pints PC 3. To withhold any anti-hypertensive
RP/LFT/Ca2+/Mg2+/PO4/C 4. Medications:
K - IV Omeprazole 40 mg OD
Iron studies - T. Ferrous fumarate 200 mg OD
TFT - T. Lovastatin 20 mg ON
PT/APTT/INR 5. To inform/refer nephro
VBG 6. Transfuse 2 pints PC with IV Furosemide 20 mg
Per rectal (PR) in between
ECG
URINE FEME
RBS (reflo) QID

Diagnosis: Viral Fever


Investigations Plans
FBC 1. Monitor vital signs
PT/APTT/INR 2. Treat accordingly
Scrub Thyphus 3. Medications:
Blood C+S - Acute pharyngitis: Thymol gargle
Urine C+S - Runny nose: T. Loratadine 10 mg TDS


Shakir Ariff Bin Zulkifli | Management of Patients

WORKOUT INVESTIGATIONS/TUBE
ALL PATIENTS FBC Purple
RP/LFT/Ca/Mg/PO4 Green
PT/APTT/INR Light blue

Anemia FBP (double forms) Purple


Se. Iron/Se. Ferritin/TIBC Red
Vit B12/Folate (double forms) Red
Hb Electrophoresis (double forms) Purple

Autoimmune ANA Red


C3, C4 Red
RF Red
dsDNA Red
ESR Red

Cancer (tumor markers) Ca125


CEA
ASA
Alpha-fetoprotein (AFP)
Ca-99 (send to HKL)

Dengue FBC Purple


RP/LFT/CE Green
Se. Lactate Grey (in ice box)
NS1/Dengue IgM Red
PT/APTT/INR Light blue
VBG
Blood Film Malaria Parasite (BFMP) x3
Leptospirosis Red

DVT Fibrinogen/D-dimer

Hemolytic FBC/Reticulocyte count/FBP Purple


LDH Red
Coomb’s Test Red
Page VSB

14 Poisoning Se. Cholinesterase Red


Se. Salicylate Red
TDM Paracetamol
Urine Paraquat Red

Septic FBC Purple


CRP Red
Blood C+S Blood C+S bottles

Thrombophilia 4 blue bottles


Tuberculosis ESR
Serum AFB x 3
Viral screening
Sputum AFB x 3
Sputum C+S
Pleural fluid AFB
Mantoux test
CXR

Viral 2 yellow bottles (double forms)


- HIV/Hep B/ Hep C/ Mycoplasma/VDRL

Shakir Ariff Bin Zulkifli | Management of Patients

NORMAL VALUES
Values Units
Hb 12 – 15 g/dL
WBC 4 – 10 10’9/L
Plt 150 – 410 10’9/L
Hct 36 – 46 %
PT 11.2 – 14.4 sec
INR 0.8 – 1.2
APTT 31.5 – 46.7 sec
Urea 2.8 – 7.2 sec
Sodium (Na) 136 – 145 mmol/L
Potassium (K) 3.5 – 5.1 mmol/L
Chloride (Cl) 98 – 107 mmol/L
Uric Acid 150 – 420 umol/L
Creatinine 45 – 84 umol/L
Total Protein 64 – 83 g/L
Albumin 35 – 50 g/L
Globulin 25 – 39 g/L
A/G Ratio 0.9 – 1.8
Total Bilirubin 3.4 – 26.0 umol/L
ALP 40 – 150 u/L
ALT < 55 u/L
AST 5 – 34 u/L
LDH 105 – 333 IU/L
Lactate 0.5 – 2.2 mmol/L
Magnesium (Mg) 0.73 – 1.06 mmol/L
Calcium (Ca) 2.10 – 2.55 mmol/L
Phosphate (PO4) 0.74 – 1.50 mmol/L
Amylase 25 – 90 u/L
Trop T < 0.1 ug/mL
Trop I < 0.04 ug/mL
CK 38 – 120 ng/mL
pH 7.35 – 7.45
pO2 75 – 100 mmHg
pCO2 35 – 45 mmHg
HCO3 22 – 28 mEg/L
BE -2 - +2
CRP 0 – 0.5 mg/L
ESR 0 – 10 mm/hour
GGT 9 – 64 u/L

High lymphocyte ​– viral, chronic bacterial


High neutrophil ​ ​– acute bacterial
Shakir Ariff Bin Zulkifli | Management of Patients

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy